S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Aimmune TherapeuticsAnaptysBioRa PharmaceuticalsInsmedHeron Therapeutics
SymbolNASDAQ:AIMTNASDAQ:ANABNASDAQ:RARXNASDAQ:INSMNASDAQ:HRTX
Price Information
Current Price$25.15$37.04$46.24$17.42$18.45
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$46.88$102.86$46.09$38.00$50.57
% Upside from Price Target86.38% upside177.69% upside-0.32% downside118.14% upside174.17% upside
Trade Information
Market Cap$1.58 billion$973.17 million$2.21 billion$1.55 billion$1.49 billion
Beta-0.081.51.342.971.42
Average Volume714,591291,718630,8981,061,874999,166
Sales & Book Value
Annual RevenueN/A$5 million$2.50 million$9.84 million$77.47 million
Price / SalesN/A200.37869.59157.9319.00
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.09 per share$18.18 per share$4.92 per share$2.70 per share$4.74 per share
Price / BookN/A2.049.406.453.89
Profitability
Net Income$-210,750,000.00$-61,660,000.00$-64,940,000.00$-324,280,000.00$-178,840,000.00
EPS($3.67)($2.50)($2.06)($4.17)($2.44)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/A-172.07%
Return on Equity (ROE)-89.68%-16.61%-45.14%-126.95%-56.89%
Return on Assets (ROA)-71.14%-15.75%-41.83%-47.66%-45.19%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.24%N/A0.02%1.01%0.04%
Current Ratio5.80%14.07%15.30%7.54%4.01%
Quick Ratio5.80%14.07%15.30%7.31%3.70%
Ownership Information
Institutional Ownership Percentage78.06%N/A91.59%N/AN/A
Insider Ownership Percentage13.75%14.00%4.30%4.95%12.56%
Miscellaneous
Employees2287872373198
Shares Outstanding62.67 million27.05 million47.02 million89.21 million79.82 million
Next Earnings Date11/14/2019 (Estimated)11/14/2019 (Estimated)11/6/2019 (Estimated)10/29/2019 (Estimated)11/6/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 Aimmune TherapeuticsAnaptysBioRa PharmaceuticalsInsmedHeron Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel